Table 3.
ADNI Cohort | Aβ Negative (n = 73) | Aβ Positive (n = 38) | ||||||
Univariate Model | Adjusted Model | Univariate Model | Adjusted Model | |||||
CSF Outcome | β ± SE | p-value | β ± SE | p-value | β ± SE | p-value | β ± SE | p-value |
Aβ42 | 0.312 ± 3.749 | 0.934 | -3.057 ± 3.934 | 0.440 | -2.640 ± 4.465 | 0.558 | 2.145 ± 5.173 | 0.682 |
t-tau | 5.848 ± 3.221 | 0.074 | 5.620 ± 3.548 | 0.118 | -1.473 ± 6.596 | 0.825 | -7.596 ± 8.355 | 0.371 |
p-tau | -0.237 ± 1.471 | 0.872 | 0.197 ± 1.614 | 0.903 | 2.483 ± 4.735 | 0.603 | -0.204 ± 6.250 | 0.974 |
NYU Cohort | Aβ Negative (n = 152) | Aβ Positive (n = 38) | ||||||
Univariate Model | Adjusted Model | Univariate Model | Adjusted Model | |||||
CSF Outcome | β ± SE | p-value | β ± SE | p-value | β ± SE | p-value | β ± SE | p-value |
Aβ42 | 12.538 ± 16.199 | 0.440 | 3.946 ± 16.398 | 0.810 | 9.641 ± 18.712 | 0.610 | 17.645 ± 24.974 | 0.486 |
t-tau | 21.980 ± 10.619 | 0.040 | 12.015 ± 10.371 | 0.249 | 171.399 ± 38.922 | < 0.001 | 100.476 ± 45.914 | 0.037 |
p-tau | 3.279 ± 1.364 | 0.017 | 2.453 ± 1.406 | 0.083 | 15.105 ± 4.435 | 0.002 | 8.037 ± 5.256 | 0.138 |
Unadjusted and adjusted linear regression models for the association of the NLR and the three outcome variables are shown (Aβ42, t-tau, p-tau). Adjusted models included age, sex, education, race, APOE4, time between CBC and CSF exams, BMI, history of hypertension, and diabetes. Aβ positivity was defined by the CSF cut-off threshold for each cohort. β coefficients, standard errors, and p-values are shown